0001415889-23-009447.txt : 20230608
0001415889-23-009447.hdr.sgml : 20230608
20230608180040
ACCESSION NUMBER: 0001415889-23-009447
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230606
FILED AS OF DATE: 20230608
DATE AS OF CHANGE: 20230608
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Santel Donald J
CENTRAL INDEX KEY: 0001293630
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40544
FILM NUMBER: 231003222
MAIL ADDRESS:
STREET 1: 4362 24TH STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94114
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aerovate Therapeutics, Inc.
CENTRAL INDEX KEY: 0001798749
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831377888
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 930 WINTER STREET
STREET 2: SUITE M-500
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-443-2400
MAIL ADDRESS:
STREET 1: 930 WINTER STREET
STREET 2: SUITE M-500
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
form4-06082023_060614.xml
X0407
4
2023-06-06
0001798749
Aerovate Therapeutics, Inc.
AVTE
0001293630
Santel Donald J
C/O AEROVATE THERAPEUTICS, INC.
930 WINTER STREET, SUITE M-500
WALTHAM
MA
02451
true
false
false
false
0
Stock Option (Right to Buy)
16.30
2023-06-06
4
A
0
12500
0
A
2033-06-05
Common Stock
12500
12500
D
The shares subject to this option will vest and become exercisable in full on the earlier of (i) June 6, 2024 or (ii) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service through the applicable vesting date.
/s/ George A. Eldridge, Attorney-in-Fact
2023-06-08